2605.14991
2026-05-15
cs.CV
cs.AI
Predicting Response to Neoadjuvant Chemotherapy in Ovarian Cancer from CT Baseline Using Multi-Loss Deep Learning
Francesco Pastori, Francesca Fati, Marina Rosanu, Luigi De Vitis, Lucia Ribero, Gabriella Schivardi, Giovanni Damiano Aletti, Nicoletta Colombo, Jvan Casarin, Francesco Multinu, Elena De Momi
发表机构
*
Department of Gynecologic Oncology, European Institute of Oncology, IEO, IRCCS, Milan, Italy(妇科肿瘤科,欧洲肿瘤研究所,IEO,IRCCS,米兰,意大利)
;
Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy(电子、信息与生物工程系,米兰理工学院,米兰,意大利)
;
Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, USA(妇产科,梅奥诊所,罗切斯特,美国)
;
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy(肿瘤学与血液肿瘤学系,米兰大学,米兰,意大利)
;
Department of Medicine and Innovative Technology, Università degli Studi dell'Insubria, Varese, Italy(医学与创新技术系,因斯布鲁克大学,瓦雷塞,意大利)
AI总结
该研究旨在通过术前增强CT影像预测卵巢癌患者对新辅助化疗的反应,以帮助早期识别无效治疗的患者。研究提出了一种基于多损失深度学习的非侵入性框架,利用自动提取的3D病灶掩膜,结合部分微调的图像编码器和注意力机制进行特征聚合与分类。实验在包含280例患者的回顾性队列上验证,模型在测试集上实现了ROC-AUC为0.73、F1得分为0.70,表明其具备一定的临床预测能力,为影像驱动的患者分层提供了可靠基础。